THR-149

N/A

Report date: 2023/11/23 10:16:39
NME

Base Information

Drug NameTHR-149
Drug Alias NameTHR 149THR-149TG-758
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionPlasma kallikrein inhibitors
TargetsPlasma kallikrein
Therapy Area/IndicationsDiabetic macular oedemaDiabetes MellitusDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaUnited StatesSlovakia +[8] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesThrombogenics IncBicycle Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesOxurion Nv
Inactive CompaniesThrombogenics
Active IndicationsDiabetic macular oedemaDiabetes MellitusDiabetic Retinopathy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A